Medication info

VIDIEN Injection (Cholecalciferol)

Prescription medicationInjectionsIntramuscular injection
Ingredient · strength
Cholecalciferol›5mg / 1mL
Manufacturer / importer
Kyungdong Pharmaceutical Co., Ltd.
Appearance
A transparent, pale yellow liquid contained in a brown glass ampoule.
Packaging
1ml x 5Amp
Approval status
Active

MFDS item code 201702092 · Notified 2017.04.25

Summary

Main use
Prevention and treatment of vitamin D deficiency
Who receives it
Adults · Children
Adult administration
Use as prescribed by a physician, adjusting the dose based on blood 25-hydroxyvitamin D levels. In adults, treatment response and tolerability should be assessed within 3 months after administration of this medicine, and the decision on whether to repeat the dose should be based on this assessment. Because adverse reactions increase with overdose, do not administer more than the required amount. Adults: Administer 200,000IU of cholecalciferol intramuscularly. Older adults: Administer 100,000IU of cholecalciferol intramuscularly. Do not exceed an annual dose of 600,000IU of cholecalciferol.
Child administration
In adolescents, treatment response and tolerability should be assessed within 6 months, and the decision on whether to repeat the dose should be based on this assessment. Adolescents: Administer 200,000IU of cholecalciferol intramuscularly.

Ingredients

Manufacturer
Kyungdong Pharmaceutical Co., Ltd.

Efficacy & effects

Prevention and treatment of vitamin D deficiency

  • Vitamin D deficiency
View approved original text

This medication is used to prevent and treat vitamin D deficiency in elderly individuals, adolescents, and adults who lack vitamin D. Insufficient vitamin D can weaken bone health, so supplementation helps maintain healthy bones. It is particularly effective in improving vitamin D deficiency in older adults and growing adolescents. Regular use of this medication alleviates symptoms of vitamin D deficiency and enhances overall skeletal health.

How it is given

Adult administration

Use as prescribed by a physician, adjusting the dose based on blood 25-hydroxyvitamin D levels. In adults, treatment response and tolerability should be assessed within 3 months after administration of this medicine, and the decision on whether to repeat the dose should be based on this assessment. Because adverse reactions increase with overdose, do not administer more than the required amount. Adults: Administer 200,000IU of cholecalciferol intramuscularly. Older adults: Administer 100,000IU of cholecalciferol intramuscularly. Do not exceed an annual dose of 600,000IU of cholecalciferol.

Child administration

In adolescents, treatment response and tolerability should be assessed within 6 months, and the decision on whether to repeat the dose should be based on this assessment. Adolescents: Administer 200,000IU of cholecalciferol intramuscularly.

Precautions

This medication contains vitamin D, so care must be taken to avoid excessive dosing. When taking vitamin D fortified foods or other vitamin D medications, it is crucial to check the total vitamin D content. If the calcium level in the blood becomes too high or the amount of calcium excreted in the urine increases, the use of this medication should be discontinued. For those with high calcium intake, it is important to regularly check calcium levels in blood and urine. Those with allergies to this medication or conditions such as hypercalcemia, kidney stones, or renal impairment should not take it. It is also safer for pregnant or breastfeeding women to avoid this medication. Various side effects, such as headaches, fatigue, muscle pain, digestive issues, dehydration, or increased blood pressure may occur during treatment; if any abnormal symptoms arise, seek medical advice. Regular blood tests to monitor vitamin D levels and kidney function are necessary. Drug interactions may occur when taken with other medications, so inform your doctor of all medications being taken. In case of an overdose, immediately stop administration, increase fluid intake, and seek necessary treatment. This medication should be used quickly after opening, and any remaining medication should be discarded. Store in a cool place away from direct sunlight.

Side effects

headache, weakness, fatigue, muscle pain, loss of appetite, weight loss, stunted growth, nausea, vomiting, constipation, diarrhea, polydipsia, polyuria, dehydration, hypertension, calcium stones, calcification of tissues such as kidneys and blood vessels, renal impairment, excessive bone calcification, arrhythmia, mental symptoms, self-awareness disturbance, joint pain, myasthenia, drowsiness, azotemia, hypersensitivity reaction, thirst, confusion, gas bloating, abdominal pain, metallic taste, dry mouth, rash, itching, hypercalciuria, hypercalcemia, hyperphosphatemia, hyperphosphaturia, injection site granuloma, injection site nodule, injection site reaction, injection site urticaria, injection site infection

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that blocks light, at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

A transparent, pale yellow liquid contained in a brown glass ampoule.

Package unit

1ml x 5Amp

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.